Ankara Etlik City Hospital
Ankara, Yenimahalle, 06010, Turkey (Türkiye)
Location status: Recruiting
Recruiting
NCT Number: NCT07228611
Assesment and Comparison of Osteoporosis Risk Factors After Stroke
The aim of this study is to evaluate the effect of these factors and stroke itself on osteoporosis developing after stroke. Thus, the expected benefit of the study is to contribute to the identification and determination of the need for treatment in high-risk patients through further studies. There are no expected risks from the study.
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
55 year–85 year
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Followed by ischemic or hemorrhagic stroke
- Between 1 week and 6 months or >1 year has passed since the date of the event
- Being between 55 and 85 years of age
Exclusion criteria
- The patient has additional neurological conditions besides stroke
- The patient has a psychiatric condition
- History of recurrent stroke
- BMD scan performed within the last year for stroke patients
- Having received osteoporosis treatment before or after the stroke
- The patient having a fragility fracture before the stroke
- The patient having a hip fracture or hip prosthesis
- The patient having an additional condition that affects physical function before the stroke (amputation, severe fracture)
- The patient has an additional disease or medication use that could cause secondary osteoporosis
- The patient's stroke did not cause physical function loss
Treatment and study plan
Bone Mineral Density
Diagnostic TestPatients who have had a stroke and are at risk of fracture, and for whom routine assessment requires Bone Mineral Density (BMD) testing, will be included in the study. In addition, patients who have already undergone BMD testing for osteoporosis screening and who present to the outpatient clinic, with similar age and comorbidities, will be screened from the system, and 28 non-stroke patients who agree to participate will be included in the study.
Primary outcomes
-
Bone Mineral Density
Time frame: First day of hospitalization
Secondary outcomes
-
Brunnstrom
Time frame: First day of hospitalization
-
Modified Barthel Index
Time frame: First day of hospitalization
-
Modified Ashworth Scale
Time frame: First day of hospitalization
-
Modified Fall Impact Scale
Time frame: First day of hospitalization
-
Vitamin D, prealbumin, and albumin
Time frame: First day of hospitalization
-
Baseline Digital Hand Dynamometer 198 LB/90 kg
Time frame: First day of hospitalization
Patients' muscle strength will be measured using a Baseline Digital Hand Dynamometer at 198 LB/90 kg for both the dominant and non-dominant extremities.
-
Measurements of quadriceps muscle thickness and biceps muscle thickness
Time frame: First day of hospitalization
Regional sarcopenia of the plegic and non-plegic extremities will also be assessed using the STAR formula with measurements of anterior thigh muscle thickness and anterior arm muscle thickness by ultrasound.
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Ankara Etlik City Hospital
Other Gov
Registry information
Official study title
Comparison of Osteoporosis Risk in the Subacute and Chronic Periods Following Stroke and Evaluation of Factors Increasing Osteoporosis
Important dates
- Study start
- 2025
- Primary completion
- 2026
- Study completion
- 2026
- First posted
- Nov 14, 2025
- Registry last updated
- Feb 24, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.